Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
481
-
Total 13F shares, excl. options
-
47M
-
Shares change
-
-910K
-
Total reported value, excl. options
-
$12.4B
-
Value change
-
-$248M
-
Put/Call ratio
-
1.19
-
Number of buys
-
200
-
Number of sells
-
-226
-
Price
-
$264.84
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2021
560 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q4 2021.
REPLIGEN CORP - COMMON STOCK (RGEN) has 481 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47M shares
of 56.2M outstanding shares and own 83.56% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.19M shares), VANGUARD GROUP INC (4.91M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.04M shares), Invesco Ltd. (1.69M shares), WCM INVESTMENT MANAGEMENT, LLC (1.36M shares), STATE STREET CORP (1.35M shares), FRED ALGER MANAGEMENT, LLC (1.22M shares), AMERIPRISE FINANCIAL INC (1.2M shares), FRANKLIN RESOURCES INC (1.07M shares), and ALLIANCEBERNSTEIN L.P. (1.04M shares).
This table shows the top 481 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.